【导读】利用核糖核酸酶靶向嵌合体（RiboTACs）降解RNA，是一种很有前景的癌症治疗方法。然而，潜在的脱靶降解是一个严重的问题。在这项研究中，团队设计了一种能触发肿瘤微环境激活的RiboTAC。2025年2月3日，苏州大学的研究团队在期刊《Nat ...

Discover the importance of vision, genetic eye disorders, and RNA-based therapies for precision treatment in India and ...

This manuscript provides important structural insights into the recognition and degradation of the host tRNA methyltransferase TRMT1 by SARS-CoV-2 protease nsp5 (Mpro). The data provide compelling ...

Disinfectants induce oxidative damage in bacteria, but a single mutation triggers the expression of genes that help the ...

Ramakrishnan, a distinguished structural biologist and Nobel Laureate in Chemistry (2009), is renowned for his groundbreaking ...

EQS-News: EVOTEC SE / Key word (s): Miscellaneous Evotec receives grant from Korean Government to develop novel antibody-based treatments for lung diseases 22.01.2025 / 07:30 CET/CEST The issuer is ...

Yonsei University, Zymedi and Evotec receive US$ 4.5m grant from the Korea Institute of Advanced Technology under the Korean Ministry for Trade, Industry and Energy Funding supports a novel ...

Request permissions for this article.

For additional information please go to www.yonsei.ac.kr. About Zymedi Zymedi is a clinical stage biopharmaceutical company pioneering novel biology of aminoacyl-tRNA synthetases (ARSs) as innovative ...